-
1
-
-
57049091723
-
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial
-
Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P: Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1977-1987.
-
(2008)
Lancet
, vol.372
, pp. 1977-1987
-
-
Skoler-Karpoff, S.1
Ramjee, G.2
Ahmed, K.3
Altini, L.4
Plagianos, M.G.5
Friedland, B.6
Govender, S.7
De Kock, A.8
Cassim, N.9
Palanee, T.10
Dozier, G.11
Maguire, R.12
Lahteenmaki, P.13
-
2
-
-
48249154985
-
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission
-
Van Damme L, Govinden R, Mirembe FM, Guedou F, Solomon S, Becker ML, Pradeep BS, Krishnan AK, Alary M, Pande B, Ramjee G, Deese J, Crucitti T, Taylor D: Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359: 463-472.
-
(2008)
N Engl J Med
, vol.359
, pp. 463-472
-
-
Van Damme, L.1
Govinden, R.2
Mirembe, F.M.3
Guedou, F.4
Solomon, S.5
Becker, M.L.6
Pradeep, B.S.7
Krishnan, A.K.8
Alary, M.9
Pande, B.10
Ramjee, G.11
Deese, J.12
Crucitti, T.13
Taylor, D.14
-
3
-
-
57049159412
-
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: Results of a phase III trial in Nigeria
-
Halpern V, Ogunsola F, Obunge O, Wang CH, Onyejepu N, Oduyebo O, Taylor D, Mc-Neil L, Mehta N, Umo-Otong J, Otusanya S, Crucitti T, Abdellati S: Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a phase III trial in Nigeria. PLoS ONE 2008; 3:e3784.
-
(2008)
PLoS ONE
, vol.3
-
-
Halpern, V.1
Ogunsola, F.2
Obunge, O.3
Wang, C.H.4
Onyejepu, N.5
Oduyebo, O.6
Taylor, D.7
Mc-Neil, L.8
Mehta, N.9
Umo-Otong, J.10
Otusanya, S.11
Crucitti, T.12
Abdellati, S.13
-
4
-
-
78649907217
-
Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000/5 Gel for the prevention of HIV infection in women: Results of the HPTN 035 trial
-
Abstract 48LB
-
Karim SA, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, Taha T, Kapina M, Maslankowski L, Soto-Torres L: Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000/5 Gel for the prevention of HIV infection in women: results of the HPTN 035 trial. CROI 2009 2009:Abstract 48LB.
-
(2009)
CROI 2009
-
-
Karim, S.A.1
Coletti, A.2
Richardson, B.3
Ramjee, G.4
Hoffman, I.5
Chirenje, M.6
Taha, T.7
Kapina, M.8
Maslankowski, L.9
Soto-Torres, L.10
-
5
-
-
13344262687
-
Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities
-
Rusconi S, Moonis M, Merrill DP, Pallai PV, Neidhardt EA, Singh SK, Willis KJ, Osburne MS, Profy AT, Jenson JC, Hirsch MS: Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities. Antimicrob Agents Chemother 1996; 40: 234-236. (Pubitemid 26020755)
-
(1996)
Antimicrobial Agents and Chemotherapy
, vol.40
, Issue.1
, pp. 234-236
-
-
Rusconi, S.1
Moonis, M.2
Merrill, D.P.3
Pallai, P.V.4
Neidhardt, E.A.5
Singh, S.K.6
Willis, K.J.7
Osburne, M.S.8
Profy, A.T.9
Jenson, J.C.10
Hirsch, M.S.11
-
7
-
-
0029655826
-
Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1
-
Pearce-Pratt R, Phillips DM: Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1. Biol Reprod 1996; 54: 173-182. (Pubitemid 126506813)
-
(1996)
Biology of Reproduction
, vol.54
, Issue.1
, pp. 173-182
-
-
Pearce-Pratt, R.1
Phillips, D.M.2
-
8
-
-
24144438231
-
Candidate sulfonated and sulfated topical microbicides: Comparison of anti-human immunodeficiency virus activities and mechanisms of action
-
DOI 10.1128/AAC.49.9.3607-3615.2005
-
Scordi-Bello IA, Mosoian A, He C, Chen Y, Cheng Y, Jarvis GA, Keller MJ, Hogarty K, Waller DP, Profy AT, Herold BC, Klotman ME: Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action. Antimicrob Agents Chemother 2005; 49: 3607-3615. (Pubitemid 41233007)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.9
, pp. 3607-3615
-
-
Scordi-Bello, I.A.1
Mosoian, A.2
He, C.3
Chen, Y.4
Cheng, Y.5
Jarvis, G.A.6
Keller, M.J.7
Hogarty, K.8
Waller, D.P.9
Profy, A.T.10
Herold, B.C.11
Klotman, M.E.12
-
9
-
-
33749541969
-
Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants
-
Fletcher PS, Wallace GS, Mesquita PM, Shattock RJ: Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology 2006; 3: 46.
-
(2006)
Retrovirology
, vol.3
, pp. 46
-
-
Fletcher, P.S.1
Wallace, G.S.2
Mesquita, P.M.3
Shattock, R.J.4
-
10
-
-
0141799911
-
Defensins: Antimicrobial peptides of innate immunity
-
Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720.
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 710-720
-
-
Ganz, T.1
-
11
-
-
59849116233
-
Levels of innate immune factors in genital fluids: Association of α defensins and LL-37 with genital infections and increased HIV acquisition
-
Levinson P, Kaul R, Kimani J, Ngugi E, Moses S, Macdonald KS, Broliden K, Hirbod T: Levels of innate immune factors in genital fluids: association of α defensins and LL-37 with genital infections and increased HIV acquisition. Aids 2009; 23: 309-317.
-
(2009)
Aids
, vol.23
, pp. 309-317
-
-
Levinson, P.1
Kaul, R.2
Kimani, J.3
Ngugi, E.4
Moses, S.5
Macdonald, K.S.6
Broliden, K.7
Hirbod, T.8
-
12
-
-
23344454141
-
Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions
-
Porter E, Yang H, Yavagal S, Preza GC, Murillo O, Lima H, Greene S, Mahoozi L, Klein-Patel M, Diamond G, Gulati S, Ganz T, Rice PA, Quayle AJ: Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 2005; 73: 4823-4833.
-
(2005)
Infect Immun
, vol.73
, pp. 4823-4833
-
-
Porter, E.1
Yang, H.2
Yavagal, S.3
Preza, G.C.4
Murillo, O.5
Lima, H.6
Greene, S.7
Mahoozi, L.8
Klein-Patel, M.9
Diamond, G.10
Gulati, S.11
Ganz, T.12
Rice, P.A.13
Quayle, A.J.14
-
13
-
-
52049124238
-
Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis
-
Fan SR, Liu XP, Liao QP: Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis. Int J Gynaecol Obstet 2008.
-
(2008)
Int J Gynaecol Obstet
-
-
Fan, S.R.1
Liu, X.P.2
Liao, Q.P.3
-
14
-
-
0027390031
-
Defensin-6 mRNA in human Paneth cells: Implications for antimicrobial peptides in host defense of the human bowel
-
DOI 10.1016/0014-5793(93)81160-2
-
Jones DE, Bevins CL: Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 1993; 315: 187-192. (Pubitemid 23015882)
-
(1993)
FEBS Letters
, vol.315
, Issue.2
, pp. 187-192
-
-
Jones, D.E.1
Bevins, C.L.2
-
15
-
-
0026457997
-
Paneth cells of the human small intestine express an antimicrobial peptide gene
-
Jones DE, Bevins CL: Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267: 23216-23225.
-
(1992)
J Biol Chem
, vol.267
, pp. 23216-23225
-
-
Jones, D.E.1
Bevins, C.L.2
-
16
-
-
0031898688
-
Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract
-
Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC: Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998; 152: 1247-1258. (Pubitemid 28221877)
-
(1998)
American Journal of Pathology
, vol.152
, Issue.5
, pp. 1247-1258
-
-
Quayle, A.J.1
Porter, E.2
Nussbaum, A.A.3
Wang, Y.M.4
Brabec, C.5
Yip, K.-P.6
Mok, S.C.7
-
17
-
-
0033017798
-
From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection
-
Fleming DT, Wasserheit JN: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17. (Pubitemid 29117474)
-
(1999)
Sexually Transmitted Infections
, vol.75
, Issue.1
, pp. 3-17
-
-
Fleming, D.T.1
Wasserheit, J.N.2
-
18
-
-
1842486661
-
The role of sexually transmitted diseases in HIV transmission
-
DOI 10.1038/nrmicro794
-
Galvin SR, Cohen MS: The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2: 33-42. (Pubitemid 39490046)
-
(2004)
Nature Reviews Microbiology
, vol.2
, Issue.1
, pp. 33-42
-
-
Galvin, S.R.1
Cohen, M.S.2
-
19
-
-
0031970166
-
Heterosexual transmission of human immunodeficiency virus type 1 (HIV): Interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1
-
Plummer FA: Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res Hum Retroviruses 1998; 14 Suppl 1:S5-S10.
-
(1998)
AIDS Res Hum Retroviruses
, vol.14
, Issue.SUPPL. 1
-
-
Plummer, F.A.1
-
20
-
-
0030604562
-
Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1
-
DOI 10.1016/S0140-6736(97)02190-9
-
Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, Zimba D, Vernazza PL, Maida M, Fiscus SA, Eron JJ Jr: Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349: 1868-1873. (Pubitemid 27270120)
-
(1997)
Lancet
, vol.349
, Issue.9069
, pp. 1868-1873
-
-
Cohen, M.S.1
Hoffman, I.F.2
Royce, R.A.3
Kazembe, P.4
Dyer, J.R.5
Daly, C.C.6
Zimba, D.7
Vernazza, P.L.8
Maida, M.9
Fiscus, S.A.10
Eron Jr., J.J.11
-
21
-
-
44449098284
-
Neisseria gonorrhoeae -induced human defensins 5 and 6 increase HIV infectivity: Role in enhanced transmission
-
Klotman ME, Rapista A, Teleshova N, Micsenyi A, Jarvis GA, Lu W, Porter E, Chang TL: Neisseria gonorrhoeae -induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J Immunol 2008; 180: 6176-6185.
-
(2008)
J Immunol
, vol.180
, pp. 6176-6185
-
-
Klotman, M.E.1
Rapista, A.2
Teleshova, N.3
Micsenyi, A.4
Jarvis, G.A.5
Lu, W.6
Porter, E.7
Chang, T.L.8
-
22
-
-
4444356630
-
Synthesis and characterization of human α-defensins 4-6
-
DOI 10.1111/j.1399-3011.2004.00179.x
-
Wu Z, Ericksen B, Tucker K, Lubkowski J, Lu W: Synthesis and characterization of human α-defensins 4-6. J Pept Res 2004; 64: 118-125. (Pubitemid 39209087)
-
(2004)
Journal of Peptide Research
, vol.64
, Issue.3
, pp. 118-125
-
-
Wu, Z.1
Ericksen, B.2
Tucker, K.3
Lubkowski, J.4
Lu, W.5
-
23
-
-
33751545243
-
Crystal structures of human α-defensins HNP4, HD5, and HD6
-
DOI 10.1110/ps.062336606
-
Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J: Crystal structures of human α-defensins HNP4, HD5, and HD6. Protein Sci 2006; 15: 2749-2760. (Pubitemid 44833756)
-
(2006)
Protein Science
, vol.15
, Issue.12
, pp. 2749-2760
-
-
Szyk, A.1
Wu, Z.2
Tucker, K.3
Yang, D.4
Lu, W.5
Lubkowski, J.6
-
24
-
-
36849093472
-
Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection
-
DOI 10.1016/j.cell.2007.10.014, PII S0092867407012846
-
Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F: Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007; 131: 1059-1071. (Pubitemid 350235017)
-
(2007)
Cell
, vol.131
, Issue.6
, pp. 1059-1071
-
-
Munch, J.1
Rucker, E.2
Standker, L.3
Adermann, K.4
Goffinet, C.5
Schindler, M.6
Wildum, S.7
Chinnadurai, R.8
Rajan, D.9
Specht, A.10
Gimenez-Gallego, G.11
Sanchez, P.C.12
Fowler, D.M.13
Koulov, A.14
Kelly, J.W.15
Mothes, W.16
Grivel, J.-C.17
Margolis, L.18
Keppler, O.T.19
Forssmann, W.-G.20
Kirchhoff, F.21
more..
-
25
-
-
58149384477
-
The cationic properties of SEVI underlie its ability to enhance HIV infection
-
Roan NR, Münch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC: The cationic properties of SEVI underlie its ability to enhance HIV infection. J Virol 2009;83:73-80.
-
(2009)
J Virol
, vol.83
, pp. 73-80
-
-
Roan, N.R.1
Münch, J.2
Arhel, N.3
Mothes, W.4
Neidleman, J.5
Kobayashi, A.6
Smith-McCune, K.7
Kirchhoff, F.8
Greene, W.C.9
|